Downstream Processing

Nov 05, 2018
By BioPharm International Editors
Fujifilm Diosynth Biotechnologies and the Centre for Process Innovation (CPI) are collaborating to complete the technology transfer of the expression and purification of model monoclonal antibodies (mAbs) as part of AMECRYS, a research project funded by the European Commission.
Nov 01, 2018
BioPharm International
The second half of this article describes the testing methods used by the authors to demonstrate the applicability of single-use mixing technology for virus inactivation.
Nov 01, 2018
BioPharm International
Survey results and record attendance may show positive signs for established and emerging biopharma regions.
Oct 01, 2018
BioPharm International
This article explores the use of single-use mixing technology in a detergent-based virus inactivation step during a monoclonal antibody production process.
Oct 01, 2018
BioPharm International
The maturation of single-use technologies presents commercial bioprocessing options for small-volume drug products.
Oct 01, 2018
By BioPharm International Editors
The companies partnered to build a 500-L single-use pilot-scale plant for biologics production.
Sep 28, 2018
BioPharm International
Testing demonstrates an automated semi-continuous process strategy for viral inactivation with steps that mimic batch processing.
Sep 28, 2018
BioPharm International
Hydrophobic interaction chromatography (HIC) in flow-through mode offers a more efficient and cost-effective polishing/purification process to remove monoclonal antibody aggregates while maintaining purity at ≥99% than a mixed-mode bind/elute procedure.
Sep 17, 2018
By BioPharm International Editors
The provider of plant-based ingredients will present recently launched multi-compendial materials for upstream and downstream biopharmaceutical applications.
Sep 07, 2018
By BioPharm International Editors
New products were developed as next-generation process intensification technologies, MilliporeSigma reports.
native1_300x100
lorem ipsum